Loading...
Atorvastatin
India Pharmaceutical Trade Intelligence
Who Supplies Atorvastatin to India from AUSTRALIA
India's atorvastatin imports from AUSTRALIA total $2.2K across 19 shipments from 6 foreign suppliers. SPRING BIO SOLUTION leads with $1.3K in import value; the top 5 suppliers together control 98.7% of this origin. Leading Indian buyers include WINDLAS BIOTECH PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for atorvastatin — a diversified sourcing base with multiple active suppliers from AUSTRALIA.
Top foreign suppliers (AUSTRALIA) — Ranked by import value
SPRING BIO SOLUTION is the leading Atorvastatin supplier from AUSTRALIA to India, with import value of $1.3K across 1 shipments. The top 5 suppliers — SPRING BIO SOLUTION, Pro Pharmaceuticals Group PTY LTD, NEWLIFE MEDICALS USA INC, ARROTEX PHARMACEUTICALS PTY LTD., AKESA PHARMA — collectively account for 98.7% of total import value from this origin.
Top foreign suppliers (AUSTRALIA)
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | SPRING BIO SOLUTION | $1.3K | 1 | 60.7% |
| 2 | Pro Pharmaceuticals Group PTY LTD | $380 | 4 | 17.2% |
| 3 | NEWLIFE MEDICALS USA INC | $171 | 4 | 7.7% |
| 4 | ARROTEX PHARMACEUTICALS PTY LTD. | $157 | 4 | 7.1% |
| 5 | AKESA PHARMA | $134 | 2 | 6.0% |
| 6 | PHARMALYTICS PTY LTD | $29 | 4 | 1.3% |
Showing top 6 of 6 foreign suppliers · Indian Customs (DGFT) · TransData Nexus
Top Indian buyers (importing from AUSTRALIA)
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | WINDLAS BIOTECH PRIVATE LIMITED | $1.3K | 1 | 60.7% |
| 2 | COPMED PHARMACEUTICALS PRIVATE LIMITED | $380 | 4 | 17.2% |
| 3 | IPCA LABORATORIES LIMITED | $171 | 4 | 7.7% |
| 4 | IND SWIFT LIMITED | $157 | 4 | 7.1% |
| 5 | MYLAN LABORATORIES LIMITED | $134 | 2 | 6.0% |
| 6 | MEDREICH LIMITED | $29 | 4 | 1.3% |
Import Statistics
- Import Value
- $2.2K
- Shipments
- 19
- Foreign Suppliers
- 6
- Indian Buyers
- 6
- Avg. Shipment
- $117
Other Atorvastatin Import Origins
Related Analysis
Frequently Asked Questions — Atorvastatin Imports from AUSTRALIA
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
QWho are the top Atorvastatin suppliers from AUSTRALIA to India?
The top Atorvastatin suppliers from AUSTRALIA to India include SPRING BIO SOLUTION, Pro Pharmaceuticals Group PTY LTD, NEWLIFE MEDICALS USA INC. The leading supplier is SPRING BIO SOLUTION with import value of $1.3K USD across 1 shipments. India imported Atorvastatin worth $2.2K USD from AUSTRALIA in total across 19 shipments.
QHow much Atorvastatin does India import from AUSTRALIA?
India imported Atorvastatin worth $2.2K USD from AUSTRALIA across 19 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
QWho are the main Indian buyers of Atorvastatin from AUSTRALIA?
The main Indian buyers of Atorvastatin sourced from AUSTRALIA include WINDLAS BIOTECH PRIVATE LIMITED, COPMED PHARMACEUTICALS PRIVATE LIMITED, IPCA LABORATORIES LIMITED. The largest buyer is WINDLAS BIOTECH PRIVATE LIMITED with $1.3K in imports across 1 shipments.
QWhat is the total value of Atorvastatin imports from AUSTRALIA to India?
The total value of Atorvastatin imports from AUSTRALIA to India is $2.2K USD, across 19 shipments and 6 foreign suppliers. Data source: Indian Customs (DGFT).
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
SS
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: AUSTRALIA to India pharmaceutical import trade corridor identified from Indian Customs (DGFT) shipping bill records for Atorvastatin.
- 2.Supplier/Buyer Matching: 6 foreign suppliers from AUSTRALIA and 6 Indian buyers identified using company name normalization across customs records.
- 3.Value Aggregation: Total import value of $2.2K aggregated from 19 verified shipping bill records. All values reported in FOB USD as recorded by Indian Customs.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
19 Verified Shipments
6 suppliers, 6 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists